Table 2.
Tamoxifen (n=42) | Aromatase inhibitors (n=65) | |||||||
---|---|---|---|---|---|---|---|---|
T1 mean (SD) | T2 mean (SD) | Absolute difference (95% CI) | P | T1 mean (SD) | T2 mean (SD) | Absolute difference (95% CI) | P | |
ETP, nM × min | 1596.8 (298.5) | 1683.0 (297.8) | +86.2 (+30.3 to +142.2) | .003 | 1531.3 (252.7) | 1575.7 (233.2) | +44.4 (−4.2 to +93.1) | .07 |
Thrombin peak, nM | 235.4 (65.8) | 268.3 (62.5) | +32.9 (+21.1 to +44.7) | <.001 | 207.2 (48.4) | 214.4 (47.2) | +7.2 (−2.5 to +16.9) | .13 |
nAPCsr | 0.86 (0.19) | 0.97 (0.19) | +0.11 (+0.06 to +0.16) | <.001 | 0.84 (0.19) | 0.84 (0.19) | 0.0 (−0.05 to + 0.05) | .91 |
nTMsr | 0.81 (0.35) | 1.07 (0.36) | +0.26 (+0.19 to +0.33) | <.001 | 0.58 (0.28) | 0.60 (0.27) | +0.02 (−0.03 to + 0.07) | .37 |